Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-14 Option Award(A) | 2026-06-15 5:24 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO | 762,200 | $0 | 762,200 (Direct) | View |
| 2026-05-14 Option Award(A) | 2026-06-15 5:24 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Kenkare-Mitra Sara Director | 126,300 | $0 | 210,500 (Direct) | View |
| 2026-05-14 Option Award(A) | 2026-06-15 5:24 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Laumas Sandeep Director | 126,300 | $0 | 210,500 (Direct) | View |
| 2026-05-14 Option Award(A) | 2026-06-15 5:24 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD | 169,500 | $0 | 169,500 (Direct) | View |
| 2026-05-14 Option Award(A) | 2026-06-15 5:23 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Townsend John CFO | 169,500 | $0 | 169,500 (Direct) | View |
| 2026-05-14 Option Award(A) | 2026-06-15 5:23 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP, Corporate Strategy | 169,500 | $0 | 169,500 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-21 4:30 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO | 762,200 | $0 | 762,200 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-21 4:30 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Kenkare-Mitra Sara Director | 126,300 | $0 | 210,500 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-20 4:30 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP, Corporate Strategy | 169,500 | $0 | 169,500 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-20 4:30 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD | 169,500 | $0 | 169,500 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-20 4:30 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Townsend John CFO | 169,500 | $0 | 169,500 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 8:57 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Laumas Sandeep Director | 126,300 | $0 | 210,500 (Direct) | View |
| 2025-08-25 Conversion | 2025-08-26 5:06 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 652,900 | $0 | 1,789,915 (Indirect) | View |
| 2025-07-28 Option Award | 2025-07-30 4:30 pm | 2026-07-28 2035-07-28 | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 21,200 | $0 | 39,200 (Direct) | View |
| 2025-07-28 Option Award | 2025-07-30 4:30 pm | 2026-07-28 2035-07-28 | Unicycive Therapeutics Inc. | UNCY | Laumas Sandeep Director | 21,200 | $0 | 41,286 (Direct) | View |
| 2025-07-28 Option Award | 2025-07-30 4:30 pm | 2026-07-28 2035-07-28 | Unicycive Therapeutics Inc. | UNCY | Kenkare-Mitra Sara Director | 21,200 | $0 | 39,200 (Direct) | View |
| 2025-07-28 Option Award | 2025-07-30 4:30 pm | N/A 2035-07-28 | Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO | 325,000 | $0 | 968,951 (Direct) | View |
| 2025-07-28 Option Award | 2025-07-30 4:30 pm | N/A 2035-07-28 | Unicycive Therapeutics Inc. | UNCY | Townsend John Chief Financial Officer | 10,000 | $0 | 101,557 (Direct) | View |
| 2025-07-28 Option Award | 2025-07-30 4:30 pm | N/A 2035-07-28 | Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD | 90,000 | $0 | 301,986 (Direct) | View |
| 2025-07-28 Option Award | 2025-07-30 4:30 pm | N/A 2035-07-28 | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy | 10,000 | $0 | 215,500 (Direct) | View |
| 2025-02-18 Conversion | 2025-02-19 11:55 am | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 1,400,000 | $0 | 11,373,271 (Indirect) | View |
| 2024-10-09 Conversion | 2024-10-10 5:15 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 5,500,000 | $0 | 9,974,037 (Indirect) | View |
| 2024-08-12 Option Award | 2024-08-14 4:15 pm | N/A 2034-08-12 | Unicycive Therapeutics Inc. | UNCY | Townsend John Chief Financial Officer | 40,256 | $0 | 915,565 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:15 pm | N/A 2034-08-12 | Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD | 81,750 | $0 | 2,119,862 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:15 pm | N/A 2034-08-12 | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy | 81,750 | $0 | 2,055,000 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 4:15 pm | N/A 2034-08-12 | Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO | 232,868 | $0 | 6,439,505 (Direct) | View |
| 2024-04-15 Option Award | 2024-04-17 4:33 pm | N/A 2034-04-15 | Unicycive Therapeutics Inc. | UNCY | Townsend John Chief Financial Officer | 228,119 | $0 | 875,309 (Direct) | View |
| 2024-04-15 Option Award | 2024-04-17 4:32 pm | N/A 2034-04-15 | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy | 463,250 | $0 | 1,973,250 (Direct) | View |
| 2024-04-15 Option Award | 2024-04-17 4:31 pm | N/A 2034-04-15 | Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD | 463,250 | $0 | 2,038,112 (Direct) | View |
| 2024-04-15 Option Award | 2024-04-17 4:31 pm | N/A 2034-04-15 | Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO 10% Owner | 1,319,583 | $0 | 6,206,637 (Direct) | View |
| 2023-09-05 Option Award | 2023-09-07 4:34 pm | N/A 2033-09-05 | Unicycive Therapeutics Inc. | UNCY | Laumas Sandeep Director | 189,236 | $0 | 200,864 (Direct) | View |
| 2023-09-05 Option Award | 2023-09-07 4:33 pm | 2024-09-05 2033-09-05 | Unicycive Therapeutics Inc. | UNCY | Kenkare-Mitra Sara Director | 180,000 | $0 | 180,000 (Direct) | View |
| 2023-09-05 Option Award | 2023-09-07 4:32 pm | N/A 2033-09-05 | Unicycive Therapeutics Inc. | UNCY | Ryan John L Director | 112,147 | $0 | 123,775 (Direct) | View |
| 2023-09-05 Option Award | 2023-09-07 4:30 pm | 2024-09-05 2033-09-05 | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 180,000 | $0 | 180,000 (Direct) | View |
| 2023-08-28 Option Award | 2023-08-30 4:47 pm | N/A 2033-08-28 | Unicycive Therapeutics Inc. | UNCY | Gupta Pramod EVP, Pharmaceuticals and BD | 1,355,000 | $0 | 1,574,862 (Direct) | View |
| 2023-08-28 Option Award | 2023-08-30 4:47 pm | N/A 2033-08-28 | Unicycive Therapeutics Inc. | UNCY | Gupta Shalabh K. CEO | 4,684,775 | $0 | 4,988,798 (Direct) | View |
| 2023-08-28 Option Award | 2023-08-30 4:46 pm | N/A 2033-08-28 | Unicycive Therapeutics Inc. | UNCY | Townsend John Chief Financial Officer | 570,329 | $0 | 647,190 (Direct) | View |
| 2023-08-28 Option Award | 2023-08-30 4:45 pm | N/A 2033-08-28 | Unicycive Therapeutics Inc. | UNCY | Jermasek Douglas EVP of Corporate Strategy | 1,355,000 | $0 | 1,510,000 (Direct) | View |
| 2023-07-11 Conversion | 2023-07-13 8:42 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 8,077 | $1000 | 59,961,729 (Indirect) | View |
| 2023-07-11 Conversion | 2023-07-13 8:42 pm | N/A N/A | Unicycive Therapeutics Inc. | UNCY | Aggarwal Gaurav Director | 59,961,729 | $0 | 59,961,729 (Indirect) | View |